Effects of dehydroepiandrosterone on aldosterone release in rat zona glomerulosa cells

被引:6
作者
Chang, Ling-Ling [1 ]
Wun, Wan-Song Alfred [2 ]
Wang, Paulus S. [3 ,4 ]
机构
[1] Chinese Culture Univ, Dept Chem Engn, Taipei 111, Taiwan
[2] Obstetr & Gynecol Associates PA, Houston, TX USA
[3] Natl Yang Ming Univ, Sch Med, Dept Physiol, Taipei 112, Taiwan
[4] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan
关键词
cAMP; DHEA; Ca2+; steroidogenesis; zona glomerulosa cells;
D O I
10.1007/s11373-008-9241-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The present study was to investigate the effects and action mechanisms of dehydroepiandrosterone (DHEA) on steroidogenesis in rat adrenal zona glomerulosa cells (ZG). ZG cells were incubated with DHEA in the presence or absence of angiotensin II (AngII), a high concentration of potassium, 8-Br-cAMP, forskolin, 25-OH-cholesterol, pregnenolone, progesterone, deoxycorticosterone, corticosterone, A23187, or cyclopiazonic acid (CPA) at 37 degrees C for 1 h. The concentration of aldosterone or pregnenolone in the culture medium was then measured by radioimmunoassay (RIA). The cells were used to determine the cellular cAMP content. The data demonstrated that: (1) DHEA inhibited AngII-, high concentration of KCl-, forskolin-, 8-Br-cAMP-, 25-OH-cholesterol-, pregnenolone-, progesterone-, deoxycorticosterone-, corticosterone-, A23187-, or CPA-stimulated aldosterone release; (2) DHEA increased 25-OH-cholesterol-stimulated pregnenolone release but not when 25-OH-cholesterol was combined with trilostane; (3) DHEA noncompetitively inhibited aldosterone synthase but showed uncompetitive inhibition of P450scc. These results suggest that DHEA acts directly on rat ZG cells to diminish aldosterone secretion by inhibition of a post-cAMP pathway or by acting on intracellular Ca2+ mobilization. In addition it affects the function of post-P450scc steroidogenic enzymes.
引用
收藏
页码:463 / 470
页数:8
相关论文
共 31 条
[1]   ROLE OF CALCIUM IN ANGIOTENSIN II-MEDIATED ALDOSTERONE SECRETION [J].
BARRETT, PQ ;
BOLLAG, WB ;
ISALES, CM ;
MCCARTHY, RT ;
RASMUSSEN, H .
ENDOCRINE REVIEWS, 1989, 10 (04) :496-518
[2]   A PROSPECTIVE-STUDY OF DEHYDROEPIANDROSTERONE SULFATE, MORTALITY, AND CARDIOVASCULAR-DISEASE [J].
BARRETTCONNOR, E ;
KHAW, KT ;
YEN, SSC .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (24) :1519-1524
[3]  
BELANGER A, 1994, J CLIN ENDOCR METAB, V79, P1086
[4]   ORAL DEHYDROEPIANDROSTERONE IN PHYSIOLOGICAL DOSES MODULATES IMMUNE FUNCTION IN POSTMENOPAUSAL WOMEN [J].
CASSON, PR ;
ANDERSEN, RN ;
HERROD, HG ;
STENTZ, FB ;
STRAUGHN, AB ;
ABRAHAM, GE ;
BUSTER, JE .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (06) :1536-1539
[5]  
CHASALOW FI, 1990, BIOL ROLE DEHYDROEPI, P317
[6]   Angiotensin II and cyclic adenosine 3′,5′-monophosphate induce human steroidogenic acute regulatory protein transcription through a common steroidogenic factor-1 element [J].
Clark, BJ ;
Combs, R .
ENDOCRINOLOGY, 1999, 140 (10) :4390-4398
[7]  
DEMAUREX N, 1992, J BIOL CHEM, V267, P2318
[8]  
GANGULY A, 1994, PHARMACOL REV, V46, P417
[9]   Aldosterone in obesity [J].
Goodfriend, TL ;
Egan, BM ;
Kelley, DE .
ENDOCRINE RESEARCH, 1998, 24 (3-4) :789-796
[10]   Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women [J].
Goodfriend, TL ;
Kelley, DE ;
Goodpaster, BH ;
Winters, SJ .
OBESITY RESEARCH, 1999, 7 (04) :355-362